INDIVUMED.COMManage supplier listing
Precision-oncology company whose core asset is IndivuType, a proprietary multi-omics plus clinical cancer database used for drug target discovery and offered in discovery/development partnerships.
Datasets
1IndivuType: proprietary multi-omics plus matched clinical cancer database assembled from a global standardised-collection clinical network, mined with graph analytics for novel target discovery; sold as discovery/development partnerships alongside patient-derived cellular models for target validation and an in-house small/large-molecule pipeline led by colorectal cancer
Coverage Health CareTickers MRK · BMY · LLYExchanges NYSE · NASDAQ
Sample, licence terms, pricing and eval results when Indivumed GmbH publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →Questions
What buyers ask about Indivumed GmbH, answered from this page.
What does Indivumed GmbH do?
Precision-oncology company whose core asset is IndivuType, a proprietary multi-omics plus clinical cancer database used for drug target discovery and offered in discovery/development partnerships.
What data does Indivumed GmbH offer?
Indivumed GmbH offers (precision-oncology multi-omics and clinical database (biobank-derived) with drug-discovery partnering).
What does Indivumed GmbH cover?
Coverage spans US; oncology, colorectal cancer (lead pipeline indication).
How do I get a sample from Indivumed GmbH?
The supplier's own access route is a contact form. Request a sample through Brickroad to start.
Indivumed GmbH has not added their own details yet. Not yet on file:
- Summary & mission
- People
- Use cases & buyers
- FAQ